Dr. Hafiza Sobia Arshad, MD

Dr. Arshad practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Dr. Arshad's NPI, 1053667980, was assigned on July 29, 2012. Dr. Arshad holds Tennessee license 57292.

Dr. Arshad's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Dr. Arshad's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Dr. Arshad is also affiliated with Cox Monett Hospital. The medical group on file is CoxHealth Neurology. Dmand AI also links Dr. Arshad to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arshad practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Arshad's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Arshad is licensed in Tennessee.

CMS data shows 817 Medicare services from Dr. Arshad across 11 procedure codes in 2024, for 330 Medicare patients. Medicare paid $46,225 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 330 Medicare patients who saw Dr. Arshad in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arshad's median patient age at 72, with 48% women.

In 2024, Dr. Arshad wrote 623 Medicare Part D claims for 118 patients. 64% of them were for generic drugs. CMS names the drug for 520 of them, across 19 drugs with 11 or more claims each, at $102,486 in total drug cost. In 2023, CMS named 697 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Arshad for performance year 2024, reported as part of a group. Dr. Arshad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Arshad in 2017. Dr. Arshad's most frequent co-authors are Rizwan Ahmed Dudekula, MD, Misbahuddin Khaja, MD and Sandeep K. Malik, MD.

CMS Open Payments shows 124 general payments to Dr. Arshad from 32 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $465.